HELP, E&C release discussion draft of User Fees Reauthorization
Read the full news articleNews
PBOA Commends Nomination of Dr. Scott Gottlieb for FDA Commissioner
March 13, 2017 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA) applauds the nomination of Dr. Scott Gottlieb to lead the Food and Drug Administration. PBOA President Gil Roth remarked, “Dr. Gottlieb brings a wealth of knowledge and perspective about the healthcare system, the structure and processes of the FDA, and the.
Read the full news articlePBOA Statement on Reauthorization of GDUFA
The Pharma & Biopharma Outsourcing Association (PBOA) lauded the news that the Food and Drug Administration (FDA) and industry have reached agreement on reauthorization of the Generic Drug User Fee Amendments (GDUFA) for a new five-year period, covering FY2018 to FY2022. PBOA was one of several industry groups that participated in GDUFA reauthorization negotiation sessions..
Read the full news articlePBOA Welcomes Groupe PARIMA
Quebec-based CDMO joins industry association
Read the full news article